CTOs on the Move

Fog Pharmaceuticals

www.fogpharma.com

 
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.fogpharma.com
  • 100 Acorn Park Drive 6th Floor
    Cambridge, MA 02140, AB USA
  • Phone: 617.945.9510

Executives

Name Title Contact Details

Funding

Fog Pharmaceuticals raised $66M on 05/16/2018

Similar Companies

Virica Biotech

Viral Sensitizers (VSE) for drug developers and manufacturers are small molecules that improve viral yields and effectiveness by reducing the antiviral defences on a cellular level.

Advantage Care Services

Advantage Care Services is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Illumina

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina`s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

West Virginia Biometrics Initiative

West Virginia Biometrics Initiative is a Charleston, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mitra Biotech

Mitra Biotech is the global leader in therapy selection in oncology. Mitra is led by an accomplished team of diagnostic and drug development professionals and is backed by world leading venture groups with long term commitment to Mitra’s vision in personalized cancer care.